$61.55
Market Cap
$579.99M
Shares Outstanding
9.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Mar 8, 2021
Round Lot
100
Locale
US
Day Open
$60.18
Day High
$62.26
Day Low
$59.89
Volume
67.4K
VWAP
$61.04
Prev Close
$59.11
Transactions
--
Acc. Volume
--
Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
Bright Minds Biosciences Inc. Common Stock (DRUG) closed the 2026-09-17 session at $61.55, up 4.13% versus the previous close (+2.44). The stock opened at $60.18 and traded between $59.89 and $62.26 during that session. Session trading volume was 67K shares. The volume-weighted average price (VWAP) is $61.04.
Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
Bright Minds Biosciences Inc. Common Stock has a market capitalization of $580.0 million. DRUG is listed on the XNAS exchange. The company employs approximately 25 people. The recorded listing date is 2021-03-08.
On this page you can find market DRUG stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.